Recall

(Image: Getty/Zozulya)

Torrent expands recall of losartan products, again

By Ben Hargreaves

Torrent announces that it will recall batches of losartan tablets for the sixth time, after the detection of NMBA exceeding acceptable daily intake levels in latest recall.

(Image: Getty/Rzarek)

Darmerica recalls API lots due to label mix-up

By Vassia Barba

Darmerica recalls two lots of product labeled as quinacrine, a compound used as a sclerosing agent, which were instead found to contain a treatment for malaria.

(Image: Getty/bong hyungjung)

The sartan saga: Recapping the recalls

By Maggie Lynch

After 2018 saw numerous sartan drugs recalled for possible carcinogenic impurities, in 2019, the industry kept an eye on the regulatory issues that followed and the breakthroughs that have mitigated some of the risks.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers